adenoma-linked barrier defects microbial products drive il-/il--mediated tumour growth 
approximately % colorectal cancer linked pre-existing inflammation known colitis-associated cancer develops patients without underlying inflammatory bowel disease colorectal cancer often follows genetic pathway whereby loss adenomatous polyposis coli apc tumour suppressor activation beta-catenin followed mutations k-ras pik3ca tp53 tumour emerges progresses curiously however inflammatory signature genes characteristic colitis-associated cancer also upregulated colorectal cancer like solid tumours colorectal cancer exhibits immune/inflammatory infiltrates referred tumour-elicited inflammation although infiltrating cd4+ th cells cd8+ cytotoxic t cells constitute positive prognostic sign colorectal cancer myeloid cells t-helper interleukin il--producing th cells promote tumorigenesis th expression signature stage i/ii colorectal cancer associated drastic decrease disease-free survival despite pathogenic importance mechanisms responsible appearance tumour-elicited inflammation poorly understood many epithelial cancers develop proximally microbial communities physically separated immune cells epithelial barrier investigated mechanisms responsible tumour-elicited inflammation mouse model colorectal tumorigenesis like human colorectal cancer exhibits upregulation il il- show il signalling promotes tumour growth progression development tumoural il response il mainly produced tumour-associated myeloid cells likely activated microbial products penetrate tumours adjacent tissue early late colorectal neoplasms exhibit defective expression several barrier proteins propose barrier deterioration induced colorectal-cancer-initiating genetic lesions results adenoma invasion microbial products trigger tumour-elicited inflammation turn drives tumour growth 
